Lv4
610 积分 2024-04-16 加入
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer
1个月前
已完结
Towards targeting the breast cancer immune microenvironment
1个月前
已完结
Prediction of checkpoint inhibitor immunotherapy efficacy for cancer using routine blood tests and clinical data
1个月前
已完结
Breast cancer statistics, 2019
9个月前
已完结
A Combined Approach of Pharmacophore Modeling, QSAR Study, Molecular Docking and In silico ADME/Tox Prediction of 4-Arylthio & 4-Aryloxy-3- Iodopyridine-2(1H)-one Analogs to Identify Potential Reverse Transcriptase Inhibitor: Anti-HIV Agents
9个月前
已完结
Biomarkers for Cyclin-Dependent Kinase 4/6 Inhibitors in the Treatment of Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced/Metastatic Breast Cancer: Translation to Clinical Practice
9个月前
已完结
Lipid-Associated Macrophages Are Induced by Cancer-Associated Fibroblasts and Mediate Immune Suppression in Breast Cancer
9个月前
已完结
SDCBP promotes pancreatic cancer progression by preventing YAP1 from β-TrCP-mediated proteasomal degradation
9个月前
已完结
Glypican-1 is a novel target for stroma and tumor cell dual-targeting antibody-drug conjugates in pancreatic cancer
9个月前
已完结
The triple negative breast cancer drugs graveyard: a review of failed clinical trials 2017-2022
9个月前
已完结
皖公网安备34019202002308
